Mouwasat Medical Reports SAR 412.38M Net Profit in the Six Months 2026
MOUWASAT 4002.SA | 0.00 |
On 2026-08-03 15:43:41 (Saudi Time), Mouwasat Medical Services Co. announced its Interim financial results for the six months ended on June 30, 2026.
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 876.44 | 796.35 | 10.057 | 833.81 | 5.112 |
| Gross Profit (Loss) | 356.41 | 341.7 | 4.304 | 342.97 | 3.918 |
| Operational Profit (Loss) | 229.39 | 203.44 | 12.755 | 207.01 | 10.811 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 211.38 | 186.97 | 13.055 | 201.01 | 5.158 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 211.38 | 186.97 | 13.055 | 201.01 | 5.158 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 1,710.24 | 1,560.7 | 9.581 |
| Gross Profit (Loss) | 699.39 | 674.77 | 3.648 |
| Operational Profit (Loss) | 436.4 | 416.69 | 4.73 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 412.38 | 384.01 | 7.387 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 412.38 | 384.01 | 7.387 |
| Total Shareholders Equity (after Deducting Minority Equity) | 3,965.39 | 3,778 | 4.96 |
| Profit (Loss) per Share | 2.06 | 1.92 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| Accumulated Losses | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
Year-on-Year Performance Drivers
For the six-month period ending 30 June 2026, Mouwasat Medical Services Co. reported revenue of SAR 1,710.24 million, up 9.581% YoY from SAR 1,560.7 million, driven primarily by the contribution of Yanbu Hospital (which commenced operations in Q1 2026), higher inpatient occupancy rates, and the positive impact of improved contractual terms with clients. Net profit attributable to shareholders rose 7.387% YoY to SAR 412.38 million from SAR 384.01 million, supported by overall revenue growth, the recognition of a capital gain of SAR 20.4 million from a land sale, and a decrease in Zakat expense following the issuance of the final Zakat assessment for 2024 and the reversal of a portion of previously recognized Zakat provisions.
Quarter-on-Quarter Performance Drivers
QoQ revenue rose 5.1% to SAR 876.44 million (vs. SAR 833.81 million in the prior quarter), driven by increased revenue contribution from Yanbu Hospital (which commenced operations in Q1 2026) and a rebound in outpatient visits following the seasonally softer Ramadan quarter. Net profit grew 5.2% QoQ to SAR 211.38 million (vs. SAR 201.01 million), supported by the higher Yanbu Hospital revenues and the recognition of a capital gain of SAR 20.4 million from the sale of land.
Other Items
The external auditor issued an unmodified conclusion with no additional comments, qualifications, or emphasis of matter paragraphs noted. No accumulated losses or fair value changes on investment properties were reported. Total shareholders' equity (after deducting minority equity) stood at SAR 3,965.39 million as of the current period, compared to SAR 3,778 million in the same period of the prior year, representing a 4.96% increase. Earnings per share for the current period were SAR 2.06, compared to SAR 1.92 in the prior year period. Certain comparative figures have been reclassified to comply with the current period presentation of the condensed consolidated interim financial statements. No material risks, going concern uncertainties, or debt covenant breaches were disclosed.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=97196&anCat=1&cs=4002&locale=arImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.